These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24588905)

  • 61. Discographic, MRI and psychosocial determinants of low back pain disability and remission: a prospective study in subjects with benign persistent back pain.
    Carragee EJ; Alamin TF; Miller JL; Carragee JM
    Spine J; 2005; 5(1):24-35. PubMed ID: 15653082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fat infiltration of paraspinal muscles is associated with low back pain, disability, and structural abnormalities in community-based adults.
    Teichtahl AJ; Urquhart DM; Wang Y; Wluka AE; Wijethilake P; O'Sullivan R; Cicuttini FM
    Spine J; 2015 Jul; 15(7):1593-601. PubMed ID: 25828477
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pilot trial of intravenous pamidronate for chronic low back pain.
    Pappagallo M; Breuer B; Lin HM; Moberly JB; Tai J; Noto C; Sanchez A; Manfredi PL
    Pain; 2014 Jan; 155(1):108-117. PubMed ID: 24060707
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.
    Huang TW; Wang CJ; Shih HN; Chang Y; Huang KC; Peng KT; Lee MS
    BMC Musculoskelet Disord; 2017 May; 18(1):209. PubMed ID: 28532408
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).
    Kim JE; Ahn JH; Jung KH; Kim SB; Kim HJ; Lee KS; Ro JS; Park YH; Ahn JS; Im YH; Im SA; Lee MH; Kim SY
    Breast Cancer Res Treat; 2011 Jan; 125(1):99-106. PubMed ID: 20922564
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ISSLS Prize Winner: Vertebral Endplate (Modic) Change is an Independent Risk Factor for Episodes of Severe and Disabling Low Back Pain.
    Määttä JH; Wadge S; MacGregor A; Karppinen J; Williams FM
    Spine (Phila Pa 1976); 2015 Aug; 40(15):1187-93. PubMed ID: 25893353
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
    George S; Weber DR; Kaplan P; Hummel K; Monk HM; Levine MA
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4163-71. PubMed ID: 26308295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass.
    Hadji P; Ziller V; Gamerdinger D; Spieler W; Articus K; Baier M; Moericke R; Kann PH
    Osteoporos Int; 2012 Jul; 23(7):2043-51. PubMed ID: 22086310
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of methylene blue on postoperative low-back pain and functional outcomes after lumbar open discectomy: a triple-blind, randomized placebo-controlled trial.
    Farrokhi MR; Lotfi M; Masoudi MS; Gholami M
    J Neurosurg Spine; 2016 Jan; 24(1):7-15. PubMed ID: 26360148
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Otaify GA; Aglan MS; Ibrahim MM; Elnashar M; El Banna RA; Temtamy SA
    Osteoporos Int; 2016 Jan; 27(1):81-92. PubMed ID: 26138583
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Effect of Zoledronic Acid on Serum Biomarkers among Patients with Chronic Low Back Pain and Modic Changes in Lumbar Magnetic Resonance Imaging.
    Koivisto K; Karppinen J; Haapea M; Järvinen J; Kyllönen E; Tervonen O; Niinimäki J; Alini M; Lotz J; Dudli S; Samartzis D; Risteli J; Majuri ML; Alenius H; Grad S
    Diagnostics (Basel); 2019 Dec; 9(4):. PubMed ID: 31817123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-induced Osteoporosis: A Randomized, Double-blind, Phase 3 Trial.
    Ward LM; Choudhury A; Alos N; Cabral DA; Rodd C; Sbrocchi AM; Taback S; Padidela R; Shaw NJ; Hosszu E; Kostik M; Alexeeva E; Thandrayen K; Shenouda N; Jaremko JL; Sunkara G; Sayyed S; Aftring RP; Munns CF
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5222-e5235. PubMed ID: 34228102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Do more MRI findings imply worse disability or more intense low back pain? A cross-sectional study of candidates for lumbar disc prosthesis.
    Berg L; Hellum C; Gjertsen Ø; Neckelmann G; Johnsen LG; Storheim K; Brox JI; Eide GE; Espeland A;
    Skeletal Radiol; 2013 Nov; 42(11):1593-602. PubMed ID: 23982421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathobiology of Modic changes.
    Dudli S; Fields AJ; Samartzis D; Karppinen J; Lotz JC
    Eur Spine J; 2016 Nov; 25(11):3723-3734. PubMed ID: 26914098
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Markers of inflammation after zoledronic acid redosing.
    Sykiotis A; Papaioannou G; Mavropoulos J; Triantaphyllopoulou M; Papandroulaki F; Ktena V; Thanou S; Pardalakis A; Kaltsa A; Karga H
    J Bone Miner Metab; 2014 Jan; 32(1):72-7. PubMed ID: 23690161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy.
    Lang JM; Wallace M; Becker JT; Eickhoff JC; Buehring B; Binkley N; Staab MJ; Wilding G; Liu G; Malkovsky M; McNeel DG
    Clin Genitourin Cancer; 2013 Dec; 11(4):407-15. PubMed ID: 23835291
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modic changes in endplates of lumbar vertebral bodies: prevalence and association with low back and sciatic pain among middle-aged male workers.
    Kuisma M; Karppinen J; Niinimäki J; Ojala R; Haapea M; Heliövaara M; Korpelainen R; Taimela S; Natri A; Tervonen O
    Spine (Phila Pa 1976); 2007 May; 32(10):1116-22. PubMed ID: 17471095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery.
    Li C; Wang HR; Li XL; Zhou XG; Dong J
    Acta Neurochir (Wien); 2012 Apr; 154(4):731-8. PubMed ID: 22297398
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
    Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
    Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes).
    Dudli S; Ballatori A; Bay-Jensen AC; McCormick ZL; O'Neill CW; Demir-Deviren S; Krug R; Heggli I; Juengel A; Karppinen J; Brunner F; Farshad M; Distler O; Lotz JC; Fields AJ
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.